Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate

Journal of the American Society of Nephrology

Volumn 18, Issue 3, 2007, Pages 868-874

  Meyer, Timothy W ^a,c   Peattie, John W T ^a   Miller, Jared D ^a   Dinh, Diana C ^a   Recht, Natalie S ^a   Walther, Jason L ^a   Hostetter, Thomas H ^b  

^a STANFORD UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CRESOL SULFATE; ACTIVATED CARBON; INDICAN; PARA CRESOL; PROTEIN; SORBENT; UNCLASSIFIED DRUG; UREA;

ARTICLE; CONTAINER; DIALYSATE; FLOW RATE; HEMODIALYSIS; HOLLOW FIBER; MATHEMATICAL MODEL; PLASMA; PLASMA CLEARANCE; PREDICTION; PRIORITY JOURNAL; SOLUTE;

EID: 33947278772     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006080863     Document Type: Article

References (29)

1. Chang TM: Assessments of clinical trials of charcoal hemoperfusion in uremic patients. Clin Nephrol 11: 111-119, 1979
2. Gurland HJ: Hemoperfusion in the treatment of uremia. Kidney Int Suppl 17: S47-S49, 1985
3. Winchester JF: Sorbent hemoperfusion in end-stage renal disease: An in-depth review. Adv Ren Replace Ther 9: 19-25, 2002
4. Mikhalovsky SV: Emerging technologies in extracorporeal treatment: Focus on adsorption. Perfusion 18[Suppl 1]: 47-54, 2003
5. Vanholder R, De Smet R, Lameire N: Protein-bound uremic solutes: The forgotten toxins. Kidney Int Suppl 78: S266-S270, 2001
6. Brunet P, Dou L, Cerini C, Berland Y: Protein-bound uremic retention solutes. Adv Ren Replace Ther 10: 310-320, 2003
7. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of the protein-bound solute p-cresol by convective transport: A randomized crossover study. Am J Kidney Dis 44: 278-285, 2004
8. Meyer TW, Leeper EC, Bartlett DW, Depner TA, Lit YZ, Robertson CR, Hostetter TH: Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes. J Am Soc Nephrol 15: 1927-1935, 2004
9. Martinez AW, Recht NS, Hostetter TH, Meyer TW: Removal of P-cresol sulfate by hemodialysis. J Am Soc Nephrol 16: 3430-3436, 2005
10. De Smet R, Van Kaer J, Van Vlem B, De Cubber A, Brunet P, Lameire N, Vanholder R: Toxicity of free p-cresol: A prospective and cross-sectional analysis. Clin Chem 49: 470-478, 2003
11. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65: 442-451, 2004
12. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y: Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69: 1081-1087, 2006
13. Michaels AS: Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs 12: 387-392, 1966
14. Meyer TW, Walther JL, Pagtalunan ME, Martinez AW, Torkamani A, Fong PD, Recht NS, Robertson CR, Hostetter TH: The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. Kidney Int 68: 867-877, 2005
15. Walther JL, Bartlett DW, Chew W, Robertson CR, Hostetter TH, Meyer TW: Downloadable computer models for renal replacement therapy. Kidney Int 69: 1056-1063, 2006
16. Yatzidis H: A convenient haemoperfusion micro-apparatus over charcoal for the treatment of endogenous and exogenous intoxication. Its use as an effective artificial kidney. Proc Eur Dial Transpl Assoc 1: 83-87, 1964
17. Yatzidis H, Yulis G, Digenis P: Hemocarboperfusion-hemodialysis treatment in terminal renal failure. Kidney Int Suppl S312-S314, 1976
18. Gelfand MC, Winchester JF: Hemoperfusion results in uremia. Clin Nephrol 11: 107-110, 1979
19. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK: Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 39: 556-570, 2002
20. Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T, Keshaviah PR: Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int 51: 2013-2017, 1997
21. Stefoni S, Coli L, Feliciangeli G, Baldrati L, Bonomini V: Regular hemoperfusion in regular dialysis treatment. A long-term study. Int J Artif Organs 3: 348-353, 1980
22. Randerson DH, Gurland HJ, Schmidt B, Farrell PC, Hone PW, Stokoe C, Zuber A, Blogg A, Fateh-Moghadam A, Marschner I, Kopeke W: Sorbent membrane dialysis in uremia. Contrib Nephrol 29: 53-64, 1982
23. Ash SR, Carr DJ, Sullivan TA: Sorbent suspension reactor for extracorporeal detoxification in hepatic failure or drug overdose. ASAIO J 50: lviii-lxv, 2004
24. Patzer JF 2nd, Bane SE: Bound solute dialysis. ASAIO J 49: 271-281, 2003
25. Evenepoel P, Maes B, Wilmer A, Nevens F, Fevery J, Kuypers D, Bammens B, Vanrenterghem Y: Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters. Blood Purif 21: 244-252, 2003
26. Whang R, Orndorff M, Papper S: Lipid-electrolyte ("lipolyte") dialysis: Experimental and preliminary clinical observations. Clin Toxicol 3: 551-560, 1970
27. Asbach HW, Holz F, Mohring K, Schuler HW: Lipid hemodialysis versus charcoal hemoperfusion in imipramine poisoning. Clin Toxicol 11: 211-219, 1977
28. Winchester JF: Dialysis and hemoperfusion in poisoning. Adv Ren Replace Ther 9: 26-30, 2002
29. Stange J, Mitzner S: A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs 19: 677-691, 1996